Search Login Register
Antineutrophil Cytoplasmic Antibodies
(ANCA)
Summary
Description:
Autoantibodies directed against cytoplasmic constituents of POLYMORPHONUCLEAR LEUKOCYTES and/or MONOCYTES. They are used as specific markers for WEGENER GRANULOMATOSIS and other diseases, though their pathophysiological role is not clear. ANCA are routinely detected by indirect immunofluorescence with three different patterns: c-ANCA (cytoplasmic), p-ANCA (perinuclear), and atypical ANCA.
Also Known As:
ANCA; Anti-Neutrophil Cytoplasmic Antibody; Antineutrophil Cytoplasmic Antibody; Antibodies, Antineutrophil Cytoplasmic; Anti-Neutrophil Cytoplasmic Antibodies Show All >>
Networked: 4376
relevant articles (219 outcomes,
402 trials/studies)
for this Bio-Agent
Key Diseases for which Antineutrophil Cytoplasmic Antibodies is
Relevant
-
Vasculitis (Vasculitides)
:
89 outcomes 121 studies in 1797 results
-
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
:
33 outcomes 50 studies in 528 results
-
Glomerulonephritis
:
29 outcomes 48 studies in 823 results
-
Wegener Granulomatosis (Wegener's Granulomatosis)
:
19 outcomes 35 studies in 733 results
-
Systemic Vasculitis
:
16 outcomes 37 studies in 466 results
Show All >>
Drugs Related to Antineutrophil Cytoplasmic Antibodies
-
Antineutrophil Cytoplasmic Antibodies (ANCA)
-
Cyclophosphamide (Cytoxan)
-
Peroxidase (Myeloperoxidase)
-
rituximab (Mabthera)
-
glucuronyl glucosamine glycan sulfate (Vessel)
-
Adrenal Cortex Hormones (Corticosteroids)
-
Prednisolone (Predate)
-
Myeloblastin (Proteinase 3)
-
Azathioprine (Imuran)
-
Autoantibodies
Show All >>
Therapies Related to Antineutrophil Cytoplasmic Antibodies
-
Kidney Transplantation
-
Aftercare (After-Treatment)
-
Transplants (Transplant)
-
Renal Dialysis (Hemodialysis)
-
Remission Induction
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.